ABCC7 p.Glu1401Gly

ClinVar: c.4202A>C , p.Glu1401Ala ? , not provided
c.4201G>T , p.Glu1401* ? , not provided
c.4202A>G , p.Glu1401Gly ? , not provided
c.4201G>A , p.Glu1401Lys ? , not provided
CF databases: c.4201G>A , p.Glu1401Lys (CFTR1) D , The new missense mutation in the exon 23 was detected by DGGE and identified by direct sequencing. The mutation was found in an isolated CBAVD patient, carrying [delta]F508 on the other allele. The mutation was not observed in 200 CFTR alleles from 100 healthy fertile males, 20 CF alleles from 10 CF patients and 90 chromosomes from 45 CBAVD patients.
c.4202A>G , p.Glu1401Gly (CFTR1) D , The mutation was identified in a CBAVD patient who was also found to carry deltaF508. No segregation analysis was performed yet. No other CFTR mutation was found after extensive screening of the coding regions. Biochemical and phylogenic inspection of the amino-acid change suggest a deleterious effect of E1401G.
c.4202A>C , p.Glu1401Ala (CFTR1) ? , This mutation was detected by multiplex DGGE and identified by direct sequencing. It was founf in a Czech CF pacient with lung disease. [delta]F508 was found on the other chromosome. The patient was referred by the department of Medical Genetics,niversity Hospital Hradec Kralove,Cz.
Predicted by SNAP2: A: N (72%), C: D (66%), D: N (66%), F: D (85%), G: N (53%), H: D (80%), I: D (80%), K: D (63%), L: D (63%), M: D (75%), N: N (57%), P: D (66%), Q: N (53%), R: D (71%), S: N (61%), T: N (53%), V: N (61%), W: D (85%), Y: D (80%),
Predicted by PROVEAN: A: N, C: N, D: N, F: D, G: N, H: N, I: N, K: N, L: N, M: N, N: N, P: N, Q: N, R: N, S: N, T: N, V: N, W: D, Y: N,

[switch to compact view]
Comments [show]
Publications
[hide] Dorfman R, Nalpathamkalam T, Taylor C, Gonska T, Keenan K, Yuan XW, Corey M, Tsui LC, Zielenski J, Durie P
Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?
Clin Genet. 2010 May;77(5):464-73. Epub 2009 Jan 6., [PMID:20059485]

Abstract [show]
Comments [show]
Sentences [show]